John M. Evans

CEO, Director, Beam Therapeutics Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$6.2M

Companies

Latest trade

Oct 16, 2026

Companies

Beam Therapeutics Inc.CEO, Director −$7.5M

Trades

BEAM Sold 25,000 shares at $23.98 · planned $0.6M Oct 16

BEAM Sold 25,000 shares at $23.57 · planned $0.6M Oct 15

BEAM Sold 25,000 shares at $34.30 · planned $0.9M Jun 30

BEAM Sold 25,000 shares at $35.49 · planned $0.9M Jun 29

BEAM Sold 30,078 shares at $24.58 · planned $0.7M Apr 1

BEAM Sold 25,000 shares at $22.76 · planned $0.6M Mar 31

BEAM Sold 25,000 shares at $22.37 · planned $0.6M Mar 30

BEAM Sold 25,000 shares at $28.35 · planned $0.7M Jan 30

BEAM Sold 25,000 shares at $29.38 · planned $0.7M Jan 29

BEAM Sold 25,000 shares at $24.63 · planned $0.6M Oct 2

BEAM Sold 25,000 shares at $24.51 · planned $0.6M Oct 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.